CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash flows from operating activities:
Net income	$ 318,161,000	$ 318,489,000	$ 247,446,000
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	81,639,000	79,456,000	64,039,000
Amortization of intangible and other assets	46,264,000	49,743,000	20,996,000
Amortization of deferred financing costs	4,984,000	7,045,000	8,023,000
Deferred income taxes	(29,156,000)	(65,527,000)	(88,402,000)
Share based compensation expense	25,099,000	22,187,000	20,947,000
Restructuring and other costs - non-cash	14,008,000	20,229,000	2,460,000
Stock option income tax benefit	(2,406,000)	(13,009,000)	(1,039,000)
Income (Loss) from Equity Method Investments	(976,000)	3,270,000	(2,351,000)
Other non-cash expense (income)	19,760,000	(15,564,000)	20,938,000
Loss (gain) on disposal of property, plant and equipment	685,000	808,000	570,000
Changes in operating assets and liabilities, net of acquisitions:
Accounts and notes receivable-trade, net	(32,532,000)	(12,591,000)	1,469,000
Inventories, net	(25,367,000)	(36,792,000)	21,503,000
Prepaid expenses and other current assets	26,929,000	(15,126,000)	(933,000)
Other noncurrent assets	(1,065,000)	853,000	(1,560,000)
Accounts payable	(36,728,000)	12,843,000	10,816,000
Accrued liabilities	(4,187,000)	(976,000)	42,218,000
Income taxes	(458,000)	22,105,000	26,139,000
Other noncurrent liabilities	13,192,000	(7,758,000)	190,000
Net cash provided by operating activities	417,846,000	369,685,000	393,469,000
Cash flows from investing activities:
Cash paid for acquisitions of businesses and equity investments	(66,247,000)	(4,861,000)	(1,787,516,000)
Capital expenditures	(100,345,000)	(92,072,000)	(71,186,000)
Purchase of company owned life insurance policies	(1,500,000)	(1,577,000)	0
Proceeds from Hedge, Investing Activities	10,784,000	0	0
Payments on settlement of net investment hedges	(104,880,000)	(14,221,000)	(25,575,000)
Expenditures for identifiable intangible assets	(1,076,000)	(3,329,000)	(3,068,000)
Liquidations of short-term investments	0	0	6,000
Proceeds from sale of property, plant and equipment	3,033,000	1,039,000	497,000
Net cash used in investing activities	(260,231,000)	(115,021,000)	(1,886,842,000)
Cash flows from financing activities:
Proceeds from long-term borrowings, net of deferred financing costs	174,628,000	0	1,106,514,000
Payments on long-term borrowings	(251,383,000)	0	(251,932,000)
Increase (decrease) in short-term borrowings	57,261,000	(228,912,000)	270,209,000
Proceeds from exercise of stock options	66,913,000	34,183,000	42,275,000
Excess tax benefits from share based compensation	2,406,000	13,009,000	1,039,000
Cash paid for contingent consideration on prior acquisitions	0	(2,519,000)	(3,023,000)
Cash paid for acquisition of noncontrolling interests of consolidated subsidiaries	(8,960,000)	0	(16,088,000)
Cash paid for treasury stock	(118,024,000)	(38,837,000)	(79,500,000)
Cash dividends paid	(34,874,000)	(31,425,000)	(28,632,000)
Proceeds from Hedge, Financing Activities	7,000	0	0
Payments for Hedge, Financing Activities	49,659,000	1,108,000	38,481,000
Net cash provided by (used in) financing activities	(161,685,000)	(255,609,000)	1,002,381,000
Effect of exchange rate changes on cash and cash equivalents	(1,108,000)	3,949,000	28,082,000
Net (decrease) increase in cash and cash equivalents	(5,178,000)	3,004,000	(462,910,000)
Cash and cash equivalents at beginning of period	80,132,000	77,128,000	540,038,000
Cash and cash equivalents at end of period	74,954,000	80,132,000	77,128,000
Supplemental disclosures of cash flow information:
Interest paid, net of amounts capitalized	50,469,000	60,166,000	34,048,000
Income taxes paid	$ 49,832,000	$ 109,544,000	$ 58,646,000